Immunosyn is a development stage company focused on the marketing and distribution of biopharmaceuticals. The company is headquartered in La Jolla, CA with a regional office in Chicago, IL and a globally positioned Scientific Advisory Board.
Immunosyn’s first product to be introduced is believed to have created an entirely new class of therapeutics made from mammalian cells that could have the ability to significantly affect many auto-immune, neurological and demyelinating conditions, consequentially quickly reducing unwanted symptoms.
The Company is committed to alleviating pain and suffering by remaining dedicated to identifying, marketing, and distributing biopharmaceuticals that work with the body, contrasting many of the drugs that work against the body. Immunosyn’s aim is to maintain as well as improve the underlying conditions of targeted diseases while simultaneously improving the quality of life for those affected.
Let us hear your thoughts: Immunosyn Corp. Message Board
